These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24643280)

  • 1. Malaria vaccine: a step toward elimination.
    Jindal H; Bhatt B; Malik JS; Sk S; Mehta B
    Hum Vaccin Immunother; 2014; 10(6):1752-4. PubMed ID: 24643280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccine can prevent millions of deaths in the world.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2013 Jun; 9(6):1268-71. PubMed ID: 23403452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and prospects for blood-stage malaria vaccines.
    Miura K
    Expert Rev Vaccines; 2016 Jun; 15(6):765-81. PubMed ID: 26760062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.
    Tinto H; Otieno W; Gesase S; Sorgho H; Otieno L; Liheluka E; Valéa I; Sing'oei V; Malabeja A; Valia D; Wangwe A; Gvozdenovic E; Guerra Mendoza Y; Jongert E; Lievens M; Roman F; Schuerman L; Lusingu J
    Lancet Infect Dis; 2019 Aug; 19(8):821-832. PubMed ID: 31300331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Promise of a Malaria Vaccine-Are We Closer?
    Laurens MB
    Annu Rev Microbiol; 2018 Sep; 72():273-292. PubMed ID: 30200856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].
    Cohen J; Benns S; Vekemans J; Leach A
    Ann Pharm Fr; 2010 Nov; 68(6):370-9. PubMed ID: 21073995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine candidates for malaria: what's new?
    Takashima E; Morita M; Tsuboi T
    Expert Rev Vaccines; 2016; 15(1):1-3. PubMed ID: 26559316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of malaria and vaccines in Kenya.
    Ojakaa D; Yamo E; Collymore Y; Ba-Nguz A; Bingham A
    Hum Vaccin; 2011 Oct; 7(10):1096-9. PubMed ID: 21941095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination.
    Vandoolaeghe P; Schuerman L
    Expert Rev Vaccines; 2016 Dec; 15(12):1481-1493. PubMed ID: 27841689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial.
    Valéa I; Adjei S; Usuf E; Traore O; Ansong D; Tinto H; Owusu Boateng H; Leach A; Mwinessobaonfou Some A; Buabeng P; Vekemans J; Nana LA; Kotey A; Vandoolaeghe P; Ouedraogo F; Sambian D; Lievens M; Tahita MC; Rettig T; Jongert E; Lompo P; Idriss A; Borys D; Ouedraogo S; Prempeh F; Habib MA; Schuerman L; Sorgho H; Agbenyega T
    Hum Vaccin Immunother; 2018 Jun; 14(6):1489-1500. PubMed ID: 29630438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
    Brooks A; Briët OJ; Hardy D; Steketee R; Smith TA
    PLoS One; 2012; 7(3):e32587. PubMed ID: 22412892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of the RTS,S malaria vaccine candidate: challenges and lessons.
    Ballou WR
    Parasite Immunol; 2009 Sep; 31(9):492-500. PubMed ID: 19691554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the circumsporozoite protein to the RTS, S/AS candidate vaccine.
    Cohen J; Nussenzweig V; Nussenzweig R; Vekemans J; Leach A
    Hum Vaccin; 2010 Jan; 6(1):90-6. PubMed ID: 19806009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of malaria vaccine clinical projects based on the WHO rainbow table.
    Schwartz L; Brown GV; Genton B; Moorthy VS
    Malar J; 2012 Jan; 11():11. PubMed ID: 22230255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RTS,S vaccine candidate for malaria.
    Regules JA; Cummings JF; Ockenhouse CF
    Expert Rev Vaccines; 2011 May; 10(5):589-99. PubMed ID: 21604980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
    von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
    Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
    [No Abstract]   [Full Text] [Related]  

  • 18. Malaria vaccines and the new malaria agenda.
    Greenwood BM; Targett GA
    Clin Microbiol Infect; 2011 Nov; 17(11):1600-7. PubMed ID: 21883665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
    Mahmoudi S; Keshavarz H
    Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.